
23.27 Delayed Data As of Sep 25 | ![]() Today’s Change | 13.73 Today|||52-Week Range 33.99 | +46.17% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $3.9B |
ACADIA Pharmaceuticals, Inc. 12830 El Camino Real San Diego California 92130-3331 |
Stephen R. Davis | Chief Executive Officer & Director |
Brendan P. Teehan | Chief Operating Officer, EVP & Head-Commercial |
Mark C. Schneyer | Chief Financial Officer & Executive Vice President |
Ponni Subbiah | Chief Medical Officer & Senior Vice President |
Sanjeev Pathak | Senior Vice President & Head-Clinical Development |